{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:01:58Z","timestamp":1782914518995,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2025 Government-Funded Program for the Training of Outstanding Clinical Medicine Talents","award":["ZF2025133"],"award-info":[{"award-number":["ZF2025133"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23975-z","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:20:00Z","timestamp":1762518000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell RNA sequencing identifies potential critical prognostic biomarkers in bladder carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Shimeng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"3","key":"23975_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"23975_CR2","doi-asserted-by":"publisher","first-page":"2438291","DOI":"10.1080\/2162402X.2024.2438291","volume":"14","author":"CG Ca\u00f1izo","year":"2025","unstructured":"Ca\u00f1izo, C. G. et al. Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer. Oncoimmunology 14 (1), 2438291 (2025).","journal-title":"Oncoimmunology"},{"key":"23975_CR3","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran, A., Cookson, M. S., Guercio, B. J. & Cheng, L. Advances in diagnosis and treatment of bladder cancer. Bmj 384, e076743 (2024).","journal-title":"Bmj"},{"issue":"6","key":"23975_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","volume":"86","author":"P Gontero","year":"2024","unstructured":"Gontero, P. et al. European association of urology guidelines on Non-muscle-invasive bladder cancer (TaT1 and carcinoma in Situ)-A summary of the 2024 guidelines update. Eur. Urol. 86 (6), 531\u2013549 (2024).","journal-title":"Eur. Urol."},{"key":"23975_CR5","doi-asserted-by":"crossref","unstructured":"Ali, W., Xiao, W., Jacobs, D. & Kajdacsy-Balla, A. Survival and enrichment analysis of Epithelial-Mesenchymal transition genes in bladder urothelial carcinoma. Genes (Basel) 14, 10  (2023).","DOI":"10.3390\/genes14101899"},{"key":"23975_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/cancers13184712","volume":"13","author":"MM Leblond","year":"2021","unstructured":"Leblond, M. M., Zdimerova, H., Desponds, E. & Verdeil, G. Tumor-Associated macrophages in bladder cancer: biological Role, impact on therapeutic response and perspectives for immunotherapy. Cancers (Basel). 13, 18 (2021).","journal-title":"Cancers (Basel)"},{"issue":"2","key":"23975_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/bju.16509","volume":"135","author":"JI Taylor","year":"2025","unstructured":"Taylor, J. I. et al. Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer. BJU Int. 135 (2), 260\u2013268 (2025).","journal-title":"BJU Int."},{"issue":"13","key":"23975_CR8","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMoa2401497","volume":"391","author":"SP Lerner","year":"2024","unstructured":"Lerner, S. P. et al. Standard or extended lymphadenectomy for Muscle-Invasive bladder cancer. N Engl. J. Med. 391 (13), 1206\u20131216 (2024).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"23975_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes, J. A. et al. European association of urology guidelines on Muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur. Urol. 79 (1), 82\u2013104. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.055 (2021).","journal-title":"Eur. Urol."},{"issue":"1","key":"23975_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t, L. et al. Bladder cancer. Nat. Rev. Dis. Primers. 9 (1), 58. https:\/\/doi.org\/10.1038\/s41572-023-00468-9 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"23975_CR11","doi-asserted-by":"crossref","unstructured":"Chen, Z. et al. Prognosis risk model based on Necroptosis-Related signature for bladder cancer. Genes (Basel) 13, 11  (2022).","DOI":"10.3390\/genes13112120"},{"key":"23975_CR12","doi-asserted-by":"publisher","unstructured":"Fang, Z., Li, J., Cao, F. & Li, F. Integration of scRNA-Seq and bulk RNA-Seq reveals molecular characterization of the immune microenvironment in acute pancreatitis. Biomolecules 13, 1. https:\/\/doi.org\/10.3390\/biom13010078 (2022).","DOI":"10.3390\/biom13010078"},{"issue":"1","key":"23975_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-023-01494-6","volume":"16","author":"D Huang","year":"2023","unstructured":"Huang, D. et al. Advances in single-cell RNA sequencing and its applications in cancer research. J. Hematol. Oncol. 16 (1), 98 (2023).","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"23975_CR14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/cas.16436","volume":"116","author":"T Lyu","year":"2025","unstructured":"Lyu, T. et al. Single-Cell RNA sequencing reveals the tumor heterogeneity and immunosuppressive microenvironment in urothelial carcinoma. Cancer Sci. 116 (3), 710\u2013723. https:\/\/doi.org\/10.1111\/cas.16436 (2025).","journal-title":"Cancer Sci."},{"issue":"1","key":"23975_CR15","doi-asserted-by":"publisher","first-page":"235237352513220","DOI":"10.1177\/23523735251322017","volume":"11","author":"K Yoshihara","year":"2025","unstructured":"Yoshihara, K., Ito, K., Kimura, T., Yamamoto, Y. & Urabe, F. Single-cell RNA sequencing and Spatial transcriptome analysis in bladder cancer: current status and future perspectives. Bladder Cancer. 11 (1), 23523735251322017. https:\/\/doi.org\/10.1177\/23523735251322017 (2025).","journal-title":"Bladder Cancer"},{"issue":"D1","key":"23975_CR16","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013D462. https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"23975_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"23975_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys, R., Saelens, W. & Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods. 17 (2), 159\u2013162. https:\/\/doi.org\/10.1038\/s41592-019-0667-5 (2020).","journal-title":"Nat. Methods"},{"issue":"1","key":"23975_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12967-025-06138-6","volume":"23","author":"J Li","year":"2025","unstructured":"Li, J. et al. Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics. J. Transl Med. 23 (1), 135. https:\/\/doi.org\/10.1186\/s12967-025-06138-6 (2025).","journal-title":"J. Transl Med."},{"issue":"8","key":"23975_CR20","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1097\/JS9.0000000000001516","volume":"110","author":"J Li","year":"2024","unstructured":"Li, J. et al. Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8\u2009+\u2009T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics study. Int. J. Surg. 110 (8), 4911\u20134931. https:\/\/doi.org\/10.1097\/JS9.0000000000001516 (2024).","journal-title":"Int. J. Surg."},{"issue":"1","key":"23975_CR21","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen, Z. et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat. Commun. 11 (1), 5077. https:\/\/doi.org\/10.1038\/s41467-020-18916-5 (2020).","journal-title":"Nat. Commun."},{"issue":"9","key":"23975_CR22","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0212-1","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng, J. et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell. Res. 29 (9), 725\u2013738. https:\/\/doi.org\/10.1038\/s41422-019-0212-1 (2019).","journal-title":"Cell. Res."},{"key":"23975_CR23","doi-asserted-by":"publisher","unstructured":"Aran, D.   Single-Cell RNA sequencing for studying human cancers. Annu. Rev. Biomed. Data Sci. ;6, 1\u201322.  https:\/\/doi.org\/10.1146\/annurev-biodatasci-020722-091857  (2023).","DOI":"10.1146\/annurev-biodatasci-020722-091857"},{"issue":"11","key":"23975_CR24","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1681\/ASN.2019040335","volume":"30","author":"Z Yu","year":"2019","unstructured":"Yu, Z. et al. Single-Cell transcriptomic map of the human and mouse bladders. J. Am. Soc. Nephrol. 30 (11), 2159\u20132176. https:\/\/doi.org\/10.1681\/ASN.2019040335 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"23975_CR25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1186\/s12967-024-06003-y","volume":"22","author":"T Tian","year":"2024","unstructured":"Tian, T. et al. YWHAG promotes bladder cancer metastasis by regulating TMOD3 to activate ERK1\/2 and JNK phosphorylation in the MAPK pathway. J. Transl Med. 22 (1), 1159. https:\/\/doi.org\/10.1186\/s12967-024-06003-y (2024).","journal-title":"J. Transl Med."},{"key":"23975_CR26","doi-asserted-by":"publisher","first-page":"1498579","DOI":"10.3389\/fonc.2024.1498579","volume":"14","author":"X Lu","year":"2024","unstructured":"Lu, X. et al. CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer. Front. Oncol. 14, 1498579. https:\/\/doi.org\/10.3389\/fonc.2024.1498579 (2024).","journal-title":"Front. Oncol."},{"issue":"5","key":"23975_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41585-019-0171-9","volume":"16","author":"JC Penticuff","year":"2019","unstructured":"Penticuff, J. C., Woolbright, B. L., Sielecki, T. M., Weir, S. J. & Taylor, J. A. MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential. Nat. Rev. Urol. 16 (5), 318\u2013328. https:\/\/doi.org\/10.1038\/s41585-019-0171-9 (2019).","journal-title":"Nat. Rev. Urol."},{"issue":"15","key":"23975_CR28","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1038\/onc.2016.367","volume":"36","author":"H Zhang","year":"2017","unstructured":"Zhang, H. et al. CXCL2\/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer. Oncogene 36 (15), 2095\u20132104. https:\/\/doi.org\/10.1038\/onc.2016.367 (2017).","journal-title":"Oncogene"},{"issue":"12","key":"23975_CR29","first-page":"2760","volume":"9","author":"MR Guda","year":"2019","unstructured":"Guda, M. R. et al. Pleiotropic role of macrophage migration inhibitory factor in cancer. Am. J. Cancer Res. 9 (12), 2760\u20132773 (2019).","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"23975_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/path.6018","volume":"259","author":"BL Woolbright","year":"2023","unstructured":"Woolbright, B. L. et al. Role of MIF1\/MIF2\/CD74 interactions in bladder cancer. J. Pathol. 259 (1), 46\u201355. https:\/\/doi.org\/10.1002\/path.6018 (2023).","journal-title":"J. Pathol."},{"issue":"5","key":"23975_CR31","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.3892\/ol.2018.8309","volume":"15","author":"JW Gai","year":"2018","unstructured":"Gai, J. W. et al. Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cells. Oncol. Lett. 15 (5), 7631\u20137638. https:\/\/doi.org\/10.3892\/ol.2018.8309 (2018).","journal-title":"Oncol. Lett."},{"key":"23975_CR32","doi-asserted-by":"publisher","first-page":"1485109","DOI":"10.3389\/fimmu.2024.1485109","volume":"15","author":"Z Zhao","year":"2024","unstructured":"Zhao, Z., Jia, H., Sun, Z., Li, Y. & Liu, L. A new perspective on macrophage-targeted drug research: the potential of KDELR2 in bladder cancer immunotherapy. Front. Immunol. 15, 1485109. https:\/\/doi.org\/10.3389\/fimmu.2024.1485109 (2024).","journal-title":"Front. Immunol."},{"key":"23975_CR33","doi-asserted-by":"publisher","first-page":"1052457","DOI":"10.3389\/fonc.2022.1052457","volume":"12","author":"JA Waters","year":"2022","unstructured":"Waters, J. A., Urbano, I., Robinson, M. & House, C. D. Insulin-like growth factor binding protein 5: diverse roles in cancer. Front. Oncol. 12, 1052457. https:\/\/doi.org\/10.3389\/fonc.2022.1052457 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"23975_CR34","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s41598-020-58136-x","volume":"10","author":"M Maimaiti","year":"2020","unstructured":"Maimaiti, M. et al. Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma. Sci. Rep. 10 (1), 1292 (2020).","journal-title":"Sci. Rep."},{"issue":"37","key":"23975_CR35","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1038\/onc.2017.149","volume":"36","author":"AL Han","year":"2017","unstructured":"Han, A. L. et al. Fibulin-3 promotes muscle-invasive bladder cancer. Oncogene 36 (37), 5243\u20135251 (2017).","journal-title":"Oncogene"},{"issue":"1","key":"23975_CR36","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12885-017-3618-5","volume":"17","author":"Y Neuzillet","year":"2017","unstructured":"Neuzillet, Y. et al. IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer. BMC Cancer. 17 (1), 636. https:\/\/doi.org\/10.1186\/s12885-017-3618-5 (2017).","journal-title":"BMC Cancer"},{"key":"23975_CR37","doi-asserted-by":"publisher","first-page":"122244","DOI":"10.1016\/j.lfs.2023.122244","volume":"335","author":"SI Nayan","year":"2023","unstructured":"Nayan, S. I. et al. Network based approach to identify interactions between type 2 diabetes and cancer comorbidities. Life Sci. 335, 122244. https:\/\/doi.org\/10.1016\/j.lfs.2023.122244 (2023).","journal-title":"Life Sci."},{"key":"23975_CR38","doi-asserted-by":"publisher","unstructured":"Harvey, J. C. et al. Analytical Validation of Cxbladder(\u00ae) Detect, Triage, and Monitor: Assays for Detection and Management of Urothelial Carcinoma. Diagn. (Basel)  14 (18). https:\/\/doi.org\/10.3390\/diagnostics14182061 (2024).","DOI":"10.3390\/diagnostics14182061"},{"key":"23975_CR39","doi-asserted-by":"publisher","unstructured":"Koll, F. J. et al. Overexpression of KMT9\u03b1 is associated with aggressive Basal-like Muscle-Invasive bladder cancer. Cells 12, 4. https:\/\/doi.org\/10.3390\/cells12040589 (2023).","DOI":"10.3390\/cells12040589"},{"issue":"5","key":"23975_CR40","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.euf.2023.03.012","volume":"9","author":"S Schallenberg","year":"2023","unstructured":"Schallenberg, S. et al. Intratumoral heterogeneity of molecular subtypes in Muscle-invasive bladder Cancer-An extensive multiregional immunohistochemical analysis. Eur. Urol. Focus. 9 (5), 788\u2013798. https:\/\/doi.org\/10.1016\/j.euf.2023.03.012 (2023).","journal-title":"Eur. Urol. Focus"},{"issue":"9","key":"23975_CR41","doi-asserted-by":"publisher","first-page":"104191","DOI":"10.1016\/j.labinv.2025.104191","volume":"105","author":"M Angeloni","year":"2025","unstructured":"Angeloni, M. et al. Robust consensus molecular subtyping of Muscle-Invasive bladder cancer via 3\u2019 RNA sequencing of Formalin-Fixed Paraffin-Embedded tissues: potential impact for clinical and trial settings. Lab. Invest. 105 (9), 104191. https:\/\/doi.org\/10.1016\/j.labinv.2025.104191 (2025).","journal-title":"Lab. Invest."},{"issue":"10","key":"23975_CR42","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2174\/1566524021666210225100041","volume":"22","author":"M Ingenwerth","year":"2022","unstructured":"Ingenwerth, M., Nyir\u00e1dy, P., Hadaschik, B., Szarvas, T. & Reis, H. The prognostic value of cytokeratin and extracellular collagen expression in urinary bladder cancer. Curr. Mol. Med. 22 (10), 941\u2013949 (2022).","journal-title":"Curr. Mol. Med."},{"issue":"8","key":"23975_CR43","doi-asserted-by":"publisher","first-page":"e0237976","DOI":"10.1371\/journal.pone.0237976","volume":"15","author":"AA Mehus","year":"2020","unstructured":"Mehus, A. A. et al. Activation of 37PPAR\u03b3 and Inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells. PLoS One. 15 (8), e0237976. https:\/\/doi.org\/10.1371\/journal.pone.0237976 (2020).","journal-title":"PLoS One"},{"issue":"51","key":"23975_CR44","doi-asserted-by":"publisher","first-page":"e32318","DOI":"10.1097\/MD.0000000000032318","volume":"101","author":"F Feng","year":"2022","unstructured":"Feng, F. et al. Identifying stage-associated hub genes in bladder cancer via weighted gene co-expression network and robust rank aggregation analyses. Med. (Baltim). 101 (51), e32318. https:\/\/doi.org\/10.1097\/MD.0000000000032318 (2022).","journal-title":"Med. (Baltim)."},{"issue":"8","key":"23975_CR45","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1158\/2326-6066.CIR-21-0802","volume":"10","author":"M Denis","year":"2022","unstructured":"Denis, M. et al. In vivo syngeneic tumor models with acquired resistance to Anti-PD-1\/PD-L1 therapies. Cancer Immunol. Res. 10 (8), 1013\u20131027. https:\/\/doi.org\/10.1158\/2326-6066.CIR-21-0802 (2022).","journal-title":"Cancer Immunol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23975-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23975-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23975-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:20:01Z","timestamp":1762518001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23975-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23975"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23975-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39105"}}